Beam Therapeutics Inc., a biotechnology company specializing in DNA base editing technologies, has recently disclosed changes in the ownership structure of its common stock. The company, which operates out of Cambridge, Massachusetts, focuses on developing innovative treatments for human diseases. Beam Therapeutics’ stock is publicly traded on the Nasdaq under the currency of USD.
On April 2, 2026, Beam Therapeutics filed several reports detailing the acquisition of restricted stock units by key senior executives and officers. These individuals include the chief legal officer, the chief medical officer, the chief financial officer, the Senior Vice President (SVP) of finance, and the president. Each of these executives received a substantial number of shares as part of the company’s 2019 equity incentive plan. The shares are set to vest over four equal installments, aligning the interests of these executives with the long-term success of the company.
The filings also provide insights into the post-transaction ownership balances, revealing that these senior executives collectively hold a significant portion of Beam Therapeutics’ shares. This concentration of ownership among top management underscores their commitment to the company’s strategic direction and growth.
Financially, Beam Therapeutics reported a close price of $24.66 on April 1, 2026. The company’s market capitalization stands at approximately $2.51 billion USD. Over the past year, the stock has experienced fluctuations, reaching a 52-week high of $36.44 on January 11, 2026, and a 52-week low of $13.54 on April 8, 2025. The price-to-earnings ratio is currently at -25.41, reflecting the company’s ongoing investment in research and development, which has yet to yield significant earnings.
No other material business events or financial data were disclosed in the recent filings. Beam Therapeutics continues to focus on its core mission of advancing DNA base editing technologies to treat human diseases, with its operations primarily serving customers in the State of Massachusetts. For more detailed information about the company’s activities and offerings, interested parties can visit their website at www.beamtx.com .
